Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
41,300
+900 (2.23%)
At close: Jul 7, 2026
Market Cap341.85B -9.5%
Revenue (ttm)16.82B +53.7%
Net Income-36.35M
EPS-4.46
Shares Out 8.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,311
Open39,050
Previous Close40,400
Day's Range39,050 - 42,850
52-Week Range37,200 - 101,000
Betan/a
AnalystsStrong Buy
Price Target97,666.67 (+136.48%)
Earnings DateAug 14, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 389650 stock is "Strong Buy." The 12-month stock price target is ₩97,667, which is an increase of 136.48% from the latest price.

Price Target
₩97,667
(136.48% upside)
Analyst Consensus: Strong Buy
Stock Forecasts